Physician
Acme Pediatric Providers PLLC
Acme Pediatric Providers PLLC was paid $10.11M by Medicaid between May 2019 and Dec 2024, across 75 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoACME PEDIATRIC PROVIDERS PLLC
HARLINGEN, TX 78550
HARLINGEN, TX 78550
33aNPI1992273692assigned 11/12/2018
33bProvider typePediatrics Physician
28Total paid$10.11M
24GClaims497,911
24DCodes billed75
24AFirst – last monthMay 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#24 of 1,136
Median peer was paid$329K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 652 | $14K | |
| 2020 | 12,221 | $235K | |
| 2021 | 93,999 | $1.89M | |
| 2022 | 134,594 | $2.71M | |
| 2023 | 136,085 | $2.78M | |
| 2024incomplete | 120,360 | $2.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 83,436 | 70,465 | $2.96M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 13% | 34,215 | 31,736 | $1.33M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10% | 78,092 | 36,465 | $1.05M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 7,539 | 7,443 | $589K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.7% | 11,604 | 11,249 | $577K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.4% | 7,378 | 7,258 | $544K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.2% | 38,801 | 36,390 | $523K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.7% | 5,759 | 5,642 | $473K |
| 94010 | 4.6% | 20,329 | 18,849 | $466K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 27,966 | 14,490 | $299K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 3,492 | 3,417 | $253K |
| 99000 | 1.2% | 12,087 | 11,506 | $125K |
63 more codes
| 80053 | Comprehensive metabolic panel | 1.1% | 13,020 | $113K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,205 | $97K |
| 87807 | <1% | 8,563 | $92K | |
| 92587 | <1% | 5,635 | $87K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,519 | $68K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 780 | $65K |
| 99381 | <1% | 671 | $52K | |
| 99383 | <1% | 596 | $50K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 781 | $46K |
| 94760 | <1% | 17,900 | $34K | |
| 90461 | <1% | 4,086 | $31K | |
| 99382 | <1% | 278 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,689 | $21K |
| 99051 | <1% | 4,453 | $20K | |
| 99384 | <1% | 210 | $19K | |
| 86308 | <1% | 4,150 | $18K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,215 | $16K |
| 83655 | <1% | 1,375 | $14K | |
| 96161 | <1% | 6,459 | $13K | |
| 81003 | <1% | 7,077 | $13K | |
| 90474 | <1% | 1,112 | $10K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 534 | $7K |
| 17110 | <1% | 41 | $4K | |
| 69209 | <1% | 297 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 279 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 76 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 81 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,065 | $2K |
| 86580 | <1% | 199 | $2K | |
| 69210 | <1% | 47 | $1K | |
| 93000 | <1% | 45 | $524.06 | |
| 97169 | <1% | 21 | $330.00 | |
| 97170 | <1% | 28 | $300.00 | |
| 90651 | <1% | 2,061 | $190.29 | |
| 81025 | <1% | 12 | $86.76 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 17,083 | $55.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 251 | $30.74 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 17,095 | $15.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 274 | $11.54 |
| 90686 | <1% | 3,896 | $2.59 | |
| 90671 | <1% | 923 | $1.32 | |
| 90621 | <1% | 1,444 | $0.40 | |
| 90620 | <1% | 177 | $0.28 | |
| 90633 | 0% | 1,968 | $0.00 | |
| 90734 | 0% | 1,655 | $0.00 | |
| 90648 | 0% | 1,866 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 467 | $0.00 |
| 90670 | 0% | 2,150 | $0.00 | |
| 90710 | 0% | 1,858 | $0.00 | |
| 90707 | 0% | 78 | $0.00 | |
| 90715 | 0% | 1,171 | $0.00 | |
| 90700 | 0% | 919 | $0.00 | |
| 90681 | 0% | 306 | $0.00 | |
| 90713 | 0% | 14 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 65 | $0.00 |
| 90696 | 0% | 995 | $0.00 | |
| 90680 | 0% | 1,232 | $0.00 | |
| 90697 | 0% | 1,126 | $0.00 | |
| 90744 | 0% | 18 | $0.00 | |
| 90723 | 0% | 1,161 | $0.00 | |
| 90619 | 0% | 329 | $0.00 | |
| 90674 | 0% | 49 | $0.00 | |
| 90716 | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUJICA, ELIZABETH (BILLING SUPERVISOR)